title: Combining biophysical screening and X-ray crystallography for fragment-based drug discovery.
abstract: Over the past decade, fragment-based drug discovery (FBDD) has gained importance for the generation of novel ideas to inspire synthetic chemistry. In order to identify small molecules that bind to a target protein, multiple approaches have been utilized by various groups in the pharmaceutical industry and by academic groups. The combination of fragment screening by biophysical methods and in particular with surface plasmon resonance technologies (SPR) together with the visualization of the binding properties by X-ray crystallography offers a number of benefits. Screening by SPR identifies ligands for a target protein as well as provides an assessment of the binding properties with respect to affinity, stoichiometry, and specificity of the interaction. Despite the huge technology advances of the past years, X-ray crystallography is still a resource-intensive technology, and SPR binding data provides excellent measures to prioritize X-ray experiments and consequently enable a better success rate in obtaining structural information. Information on the chemical structures of fragments binding to a protein can be used to perform similarity searches in compound libraries in order to establish structure-activity relationships as well as to explore particular scaffolds. At Roche we have applied this workflow for a number of targets and the experiences will be outlined in this review.
authors.affiliation: F. Hoffmann-La Roche Ltd., Basel, Switzerland. Michael.Hennig@Roche.com
authors.forename: Michael
authors.initials: M
authors.lastname: Hennig
authors.forename: Armin
authors.initials: A
authors.lastname: Ruf
authors.forename: Walter
authors.initials: W
authors.lastname: Huber
mesh_terms: D018360:Crystallography, X-Ray; D055808:Drug Discovery / Q000379:methods*; D057166:High-Throughput Screening Assays; D008958:Models, Molecular; D054852:Small Molecule Libraries / Q000032:analysis / Q000737:chemistry* / Q000494:pharmacology; D013329:Structure-Activity Relationship; D020349:Surface Plasmon Resonance
chemical_list: D054852:Small Molecule Libraries